Isaac Blanca

Dr. Isaac Blanca

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2024 in Immuno
Verified
Journal Article
Open access
PDF file
JGJenny Valentina Garmendia
Jenny Valentina Garmendia
IBIsaac Blanca
Isaac Blanca
MPMaría Johanna Peña
María Johanna Peña
CSClaudia De Sanctis
Claudia De Sanctis
Juan Bautista De SanctisJuan Bautista De Sanctis
Juan Bautista De Sanctis
In recurrent pregnancy loss (RPL), peripheral and local immune cells are activated, decreasing the leukocyte tolerogenic response in the uterus and decidua. The aim was to examine the role of IL-17 in RPL critically. The study included genetic polymorphism, the analysis of the number of circulating IL-17 lymphocyte populations, before and after cell priming, serum cytokine quantification, and the assessment of T-reg cells in a group of 50 RPL and 50 normal women from the admixed Venezuelan population. The study found no differences in the genetic polymorphisms rs2275913 and rs763780. However, when IL-17+ cell populations of controls and RPL patients were compared, a significant increase was observed in the cell populations CD3+ and CD4+ (p < 0.001), while the contrary was recorded in CD8+ and CD56+ cells. Upon cell priming, all IL-17+ populations were significantly decreased (p < 0.001) in RPL patients compared to controls. The increase in IL-17A in the serum of RPL patients may be due to the CD4+ population, while cell exhaustion after activation could be responsible for decreased CD8+ cell population. The number of CD4CD25 FoxP3+ cells was significantly reduced (p < 0.001), and the number of activated HLADR+ cells was significantly increased (p < 0.001) in RPL patients. The absence of differences in the genetic polymorphism compared to controls suggests that biological factors influence IL-17 levels in RPL patients. This finding has significant implications for the understanding and potential treatment of RPL.

1 January 2025 in Revista Veterinaria
Verified
Journal Article
Open access
PDF file
MDM. A. Duarte
M. A. Duarte
ENE. Navarro
E. Navarro
JCJ. Carballo
J. Carballo
ENE. Negrón
E. Negrón
IBIsaac Blanca
Isaac Blanca
ACA. F. Convit
A. F. Convit
Los modelos animales son parte fundamental de la investigación científica preclínica en el desarrollo de nuevas terapias, incluyendo drogas y terapias génicas. Para tales fines, es crucial contar con un modelo animal acorde con el estudio a realizar. En el bioterio de la Unidad Experimental de Inmunoterapia (UEI) de la Fundación Jacinto Convit (FJC) se estructuró una colonia de ratones BALB/c a fin de contar con una cepa pura para llevar a cabo proyectos de investigación experimental en cáncer de mama, utilizando la línea de células de tumor autólogo 4T1. Esta colonia se estableció a partir de dos parejas de ratones BALB/c proporcionados por la Universidad Simón Bolívar, asegurando condiciones estrictas de alojamiento en microaisladores, con alimentación adecuada, enriquecimiento ambiental y control detallado del micro y macroambiente requerido para la especie. El cuidado de los animales estuvo a cargo de un biólogo especializado. La expansión de esta cepa de ratones BALB/c se evaluó siguiendo un esquema de cruces endogámicos programados en cada tercer parto. La homocigosidad se determinó mediante la técnica de injerto de piel entre individuos de la misma cepa y el análisis comparativo de microsatélites. Se analizaron los datos obtenidos de 135 partos, con un máximo de 6 partos por caja reproductora, provenientes de parejas monógamas donde no ocurrieron muertes inesperadas y se obtuvo en promedio de 6,25 ± 2,38 crías por parto, y un periodo interparto de 27 ± 7,5 días. El conjunto de los resultados obtenidos en este trabajo demostró que el protocolo de reproducción, cuidado y mantenimiento de la colonia de ratones BALB/c en el bioterio de la UEI de la FJC, es eficaz para garantizar la expansión y pureza genética de esta cepa, en adelante denominada BALB/c//USB//FJC.

13 November 2025 in Immuno
Verified
Journal Article
Open access
PDF file
JGJenny Valentina Garmendia
Jenny Valentina Garmendia
IBIsaac Blanca
Isaac Blanca
Juan Bautista De SanctisJuan Bautista De Sanctis
Juan Bautista De Sanctis
Killer-cell immunoglobulin-like receptors (KIRs) play a crucial role in the cytotoxic activity of natural killer (NK) cells, encompassing both inhibitory and activating types. A higher ratio of cytotoxic to inhibitory receptors may harm successful pregnancies by disrupting the uterine environment. Ongoing debates surround the impact of KIR gene variations on recurrent pregnancy loss (RPL) and infertility across populations. This study aimed to explore KIR gene polymorphisms in RPL and infertility among the Venezuelan admixed population. The Venezuelan population exhibits a genetic mix of Caucasian, African, and local Amerindian ancestry, distinguishing it from other Latin American admixed populations. This study included 100 controls and 86 patients: 73 women with idiopathic RPL (53 primary and 20 secondary) and 13 infertile patients (4 primary and 9 secondary). The frequency of activating receptors KIR2DS2 and KIR2DS3 was significantly lower (p < 0.05) in the whole patient group compared to controls. However, when analyzing the haplotypes and genotypes, the significance between patients and controls was lost. When comparing RPL and infertile patients, KIR2DS2, KIR2DL3, 2DL5, and 3DL1 were significantly less frequent in infertile women. In infertile women, KIR2DS3 frequency was increased compared to controls and RPL. The results suggest that the frequency of inhibitory receptors may differentiate patients with RPL and infertility. Further studies should ascertain the expression and function of KIRs in uterine NK cells in patients with RPL and infertility.

6 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JGJenny Valentina Garmendia
Jenny Valentina Garmendia
IBIsaac Blanca
Isaac Blanca
MPMaría Johanna Peña
María Johanna Peña
CSClaudia De Sanctis
Claudia De Sanctis
Juan Bautista De SanctisJuan Bautista De Sanctis
Juan Bautista De Sanctis
The immune response is crucial in Pregnancy Loss (RPL), which affects 1-2% of women. In RPL, peripheral blood lymphocytes and local immune cells are activated with a concomitant decrease in the leukocyte tolerogenic response in the uterus and decidua. IL-17 plays an essential role in T cell activation, weakening tolerogenic responses of the T cells. The report aims to analyze the IL-17 genetic polymorphism, circulating IL-17 lymphocyte populations, the reaction upon lymphocyte priming, the amount of cytokine in serum, and the number of T-reg cells in a group of 50 RPL and 50 normal women from the admixed Venezuelan population. No differences were observed in the genetic polymorphisms rs2275913 and rs763780. A significant decrease (P<0.001) was observed in RPL patients compared to controls in the IL-17+ cell populations CD3+, CD8+, CD56+, and CD4CD25 FoxP3, but not in the CD4IL17+ cells. The response upon cell priming was significantly decreased (P<0.001) in all subpopulations of RPL as compared to controls. It is concluded that despite the increase in IL-17A in the serum of patients, the number of circulating IL-17 cells and the lymphocyte response to stimulation was significantly decreased (p<0.001). No differences in the genetic polymorphism compared to controls suggest that biological factors influence IL-17 levels in RPL patients, which must be carefully studied.

19 December 2025 in Immuno
Verified
Journal Article
Open access
PDF file
JGJenny Valentina Garmendia
Jenny Valentina Garmendia
IBIsaac Blanca
Isaac Blanca
Juan Bautista De SanctisJuan Bautista De Sanctis
Juan Bautista De Sanctis
Unexplained infertility and idiopathic recurrent pregnancy loss (RPL) have a prevalence of 1–5% of women of reproductive age in different populations. There are a few reports comparing the circulating immune cell populations and subpopulations in these medical entities in admixed populations. The study aimed to assess the different leukocyte, mononuclear cell populations, and T lymphocyte subpopulations and HLADR expression, as a marker of activation, in an admixed group of Venezuelan women: 80 controls, 73 women with RPL (53 primary, 20 secondary), and 26 infertile (20 primary, six secondary). Endometriosis was clinically ruled out in all patients and controls. Total leukocytes were 10–12% higher (p < 0.0001) in the infertile group, while neutrophils were 11% in the infertility group (p < 0.0001). In contrast, lymphocytes, CD3CD4 cells, NK cells, and HLADR+ cells were elevated (10–15, 18–22, 50–60, and 700–800% increase, respectively) in all patient groups. Changes in B cell numbers and monocyte counts were also observed. HLADR expression was significantly increased (p < 0.0001) in T cells, CD56+ cells, and monocytes of all patients. In infertile patients, a correlation was recorded between HLADR and T memory cells. Marked differences in peripheral blood leukocytes, NK cells, monocytes, T-cell populations, and HLADR suggest a proinflammatory effect. HLADR can be used as a simple biomarker to monitor pharmacological treatment in these patients.